Five key facts about the market for insulins

A century ago, patients were treated with animal insulins. Today, biopharmaceutical companies produce insulins that operate at the molecular level, more closely resembling insulin released naturally in the body and more effectively managing the disease. The options available today also help meet a wide range of unmet needs, providing patients with the tools necessary to stay adherent and healthy – saving costs throughout the health care system. However, this innovation isn’t enough if patients can’t afford their insulin and other medicines at the pharmacy.
Source: The Catalyst - Category: Pharmaceuticals Tags: diabetes Out of Pocket Costs Pharmacy Benefit Managers Let's Talk About Cost Source Type: news